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Drug Eluting Stents In Female Diabetic Patients With Acute Myocardial
Infarction Undergoing Primary Percutaneous Coronary Intervention
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Background: The aim of study was to compare different coronary stents used during
primary percutaneous coronary intervention (PCI) in female patient with acute
myocardial infarction (AMI) and diabetes mellitus (DM).
Methods: We selected 1799 consecutive AMI female patients (68.910.2) with DM
undergoing primary PCI and divided them into 5 groups based on the types of drug eluting
stents implanted. Sirolimus-eluting stent (SES), Paclitaxel-eluting stent (PES), Ever-
olimus-eluting stent (EES), Biolimus-eluting stent (BES), Zotarolimus-eluting stent
(ZES). Study end point was 12-monthmajor adverse cardiac events (MACE), a composite
of death, fatal and nonfatal myocardial infarction and target vessel revascularization.
Results:Mean Hemoglobin A1c level of SES, PES, EES, BES, ZES was 7.7  1.1%,
7.8 1.3%, 7.8  1.1%, 7.6  1.2%, and 7.7  1.2% respectively (p¼0.195). 928
patients (51.6%) patients prescribed oral hypoglycemic agents (OHA) and 871 pa-
tients prescribed OHA and insulin both.Ejection fraction, systolic blood pressure were
no signiﬁcant difference in ﬁve groups. The incidence of 12-month MACE in SES,
PES, EES, BES, ZES was 8.3%, 8.9%, 4.2%, 4.5%, and 5.2%, respectively (p¼0.02).
Kaplan Meier analysis show signiﬁcant difference between SES and BES (p¼0.046),
SES and EES (p¼0.025), PES and BES (p¼0.021), PES and ZES (p¼0.039), PES and
EES (p¼0.011). Independent predictors of one-year MACE were family history (OR
17.06, 95% CI 8.412-34.61, p< 0.001), serum glucose level(OR 0.304, 95% CI 0.140-
0.661, p¼0.024), serum creatine level (OR 3.933, 95% CI 1.194-12.96, p¼0.024).
Conclusions: In female patient with AMI and DM, EES and BES would be better
therapeutic option than SES and PES for one-year follow up and this result warranted
further long-term follow-up.
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Background: Risk stratiﬁcation is of utmost importance in patients with ST-elevation
myocardial infarction (STEMI) treated with primary percutaneous coronary inter-
vention (pPCI). We aimed to compare different risk scores to evaluate their predictive
power towards in-hospital outcomes.
Methods: In 241 consecutive STEMI patients referred for pPCI, the GRACE, TIMI,
Zwolle, CADILLAC, PAMI, SYNTAX, and residual SYNTAX (rSS) scores were
calculated. The endpoints of this study were in-hospital death, major adverse cardiac
events (MACE: death, recurrent myocardial infarction and urgent revascularization)
and major adverse events (MAE: MACE, heart failure, stroke, acute kidney injury and
major bleeding). The C-statistic was utilized for comparisons.
Results: Mean age was 62.212.6 years, 77.2% were male and 16.2% diabetics. Mean
ejection fraction was 47.89.6%. The culprit lesion was the LAD in 38.6% and 44.4%
had multivessel disease. All scores were signiﬁcantly associated with the 3 outcomes on
univariate analysis, except the rSS (with death,MACEandMAE).As shown in theTable,
the GRACE score showed the highest C-statistic for all endpoints: death (0.8866, 95%
CI: 0.8058 to 0.9674), MACE (0.8168; 95% CI: 0.7078 to 0.9258) and MAE (0.7922,
95% CI: 0.7151 to 0.8693). The GRACE score signiﬁcantly outperformed the other
6 scores for all 3 endpoints (except the Zwolle and CADILLAC risk scores for MAE).Conclusions: In a contemporary population of STEMI patients treated with
pPCI, the GRACE score was the best predictor of in-hospital death, MACE
and MAE.B16 JACC Vol 64/11/Suppl B jTCT-55
Has PRAMI Changed Practice? An International Survey of Approaches to the
Management of Non-Culprit Lesions in Patients Undergoing Primary
Percutaneous Coronary Intervention (PCI) for ST-Elevation Myocardial
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Background: The recent PRAMI trial has shown that in patients with STEMI, im-
mediate preventive PCI to non-culprit lesions reduced the risk of major adverse car-
diovascular events (MACE). We conducted an online survey to assess current
approaches and to determine whether the PRAMI results are being translated into
clinical practice.
Methods: Email invitations to participate in a SurveyMonkey questionnaire were
sent to interventional cardiologists in the United Kingdom (UK), United States of
America (USA), Switzerland and Australia and New Zealand (ANZ).
Results: Of the 288 responses, 146 (50.7%) were from the UK, 59 (20.5%) from
USA, 39 (13.6%) from Switzerland, and 44 (15.2%) from ANZ. The majority of
respondents opted for medical therapy for lesions of 50-70% severity (n¼196, 76.1%)
and staged PCI for lesions of 70-90% severity (n¼203, 76.6%). In patients with >90%
stenosis, 28.2% (n¼77) opted for immediate PCI and 65.6% (n¼179) for staged PCI.
Respondents most frequently opted to perform staged PCI during the index admission
for stenoses of >90% severity (n¼121, 47.8%) and to delay it for 4-6 weeks for other
lesion severities (n¼192, 43.7%). Most respondents were either uncertain that im-
mediate preventive PCI prevents MACE (n¼119, 41.3%) or did not believe that it
does (n¼125, 43.4%).Conclusions: Only a minority of interventional cardiologists are persuaded that pre-
ventive PCI reduces the risk of MACE. Furthermore, most would perform staged
rather than immediate PCI. Further studies are required to conﬁrm or refute the
PRAMI results and to address the optimal timing of PCI to non-culprit lesions.
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Background: It has been shown that higher Residual Platelet Reactivity RPR
(P2Y12-Reaction-Units,PRU>251.5) after clopidogrel loading is associated with
larger intracoronary thrombus burden, as well as with impaired myocardial perfusionSeptember 13–17, 2014 j TCT Abstracts/Acute Myocardial Infarction
Table. Comparison of demographic and clinical variables of patients.
ES-PCI
n:55
LS-PCI
n:89
P value
Age (year) 57.6612.3 57.911 0,884
DM, n (%) 6 (22.2) 21 (78.8) 0.058
Chest pain duration (hour) 2.41.6 2.11.8 0.475
STEMI Type
Inferior MI (%) 15 (27.2%) 41 (46%) 0.025
Posterior MI (%) 2 (3.6%) 3 (3.3%) 0.933
Inferoposterior MI (%) 9 (16.3%) 11 (12.3%) 0.500
Lateral MI (%) 3 (5.4%) 1 (1.1%) 0.124
Anterior MI (%) 25 (45.4%) 30 (33.7%) 0.159
Inferolateral MI (%) 1 (1.8%) 3 (3.3%) 0.582
Door to balloon time (minutes) 17,94,4 18.05.1 0,135
EF (%) at 3th month 53.212.1 57.110 0,135
Timing of second PCI (days) 3.93.5 35.511.2 0.000
Patient presentation
Asymtomatic (%) 50 (90.9%) 55 (61.8%) 0,000
Sudden death (%) 0 (0.0%) 0 (0.0%) 1,000
Stabil angina (%) 2 (3.6%) 12 (13.5%) 0,053
Acute Coronary Syndrome (%) 3 (5.5%) 22 (24.7%) 0,001
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMafter revascularization. We investigated whether RPR is further correlated with long
term major adverse clinical events among ST-elevation myocardial infarction
(STEMI) patients undergoing an unexpectedly-delayed primary PCI.
Methods: A retrospective observational study was conducted, including patients with
STEMI, who were either transferred from a referring hospital or presented directly to
our hospital and unexpectedly failed to achieve the goal of a ﬁrst medical contact-to-
balloon time of less than 2h. VerifyNow assay was used to determine RPR after
clopidogrel loading. Study population was divided into Low and High RPR groups
(PRU< 251.5 and PRU>251.5 respectively) according to the previously published
study. Major adverse clinical events (MACE) (cardiovascular death, stroke, myocar-
dial infarction, revascularization) were recorded in long term follow up.
Results: A total of 61 consecutive STEMI patients (mean age 62.1312 yrs, 48
males) were enrolled in the study. Low RPR group included 38 patients (62.3%),
while high RPR group included 23 patients (37.7%). In long term follow up (mean
follow-up period 33 19 months), it was found that among patients with high RPR,
MACE were more frequent in comparison with the low RPR group (p¼0.043, phi
coefﬁcient¼ 0.3). After adjustment for age, diabetes mellitus and ejection fraction at
hospital exit, high RPR group remained an independent predictor of MACE (OR:
4.478, CI: 1.001-20.096; p¼0.05). To further investigate the prognostic value of high
RPR in clinical outcomes, by Cox proportional hazards regression model, it was
shown that high RPR levels, is an independent prognostic factor for MACE-free
survival among STEMI patients undergoing primary PCI [hazard ratio: 0.282, 95%
conﬁdence interval (0.093–0.854), P ¼ 0.025].
Conclusions: Among STEMI patients undergoing primary PCI, those with initial
PRU levels above the cutoff point of 251.1, have higher incidence of major adverse
cardiac events during long term follow up.
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Background: Several observational studies suggested that co-existence of the sig-
niﬁcant stenosis in the non-infarct related coronary artery worsened clinical outcome
of the patient with acute myocardial infarction (AMI). However, there is a paucity of
data regarding the impact of chronic total occlusion (CTO) in non-infarct coronary
artery on prognosis in patients with AMI.
Methods: We retrospectively evaluated 429 consecutive patients with AMI who
underwent primary percutaneous coronary intervention in our hospital between
January 2008 and December 2012. AMI patients complicated with cardiopulmonary
arrest out of the hospital, having the left main trunk culprit lesion, and diagnosed after
24 hours from the symptoms onset were excluded.
Results: Of those, 41 (9.6%) patients had CTO lesions in a non-infarct related artery
(CTO patients). Those patients were signiﬁcantly more likely to be associated with
cardiogenic shock (30.2% vs 11.6%; p< 0.01) and to require an extracorporeal membrane
oxygenator (ECMO) because of cardiopulmonary arrest in the emergency department or
catheterization laboratory (12.2% vs 2.3%; p< 0.001) when compared with patients
without CTO lesion (non CTO patients). Intraaortic balloon pumping also is also required
in 28 (68.3%) CTO patients. Despite peak creatinine kinase level between 2 groups was
similar (2815 U/L vs 2116 U/L), the left ventricular ejection fraction estimated by
echocardiography after primary PCI was signiﬁcantly lower in CTO patients as compared
with non CTO patients (45.3% vs 54.8%; p< 0.0001). The in-hospital mortality and
30-days mortality were signiﬁcantly higher in CTO patients as compared with non
CTO patients (19.5% vs 4.6%; p< 0.0001, 14.6% vs 3.4%; p< 0.001, respectively).
Conclusions: AMI patients associated with CTO lesions required more frequent use
of assist devices and had signiﬁcantly poor outcome as compared with those without
CTO lesion.
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Background: There is no clear data in the literature about timing of second percu-
taneous coronary intervention (PCI) to critical non-culprit lesion after primary PCI
(p-PCI). In this study, we aimed to investigate the optimal timing of second PCI to
critical non-culprit lesions in STEMI patients who underwent primary PCI with
critical multi vessel coronary artery disease(MV-CAD).
Methods: 718 consecutive acute STEMI patients undergoing p-PCI within 12 hours
after chest pain onset were evaluated in this study. However, 394 (54.8%) STEMIJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Acpatients with one vessel disease were excluded from the study. Our study included 324
acute STEMI patients with MV-CAD. The patients were divided into two groups ac-
cording to the timing of the second PCI to non-infarct related critical coronary artery
lesions. Patients who underwent second PCI to non-culprit lesion in the ﬁrst 15 days was
accepted as early secondary PCI group (ES-PCI, n¼55); and patients who underwent
second PCI to non-culprit lesion after 15 days was accepted as late secondary PCI group
(LS-PCI, n¼89). The characteristic of p-PCI and second angiography datas were
recorded. We evaluated the patients completely before discharge and at the 3rd month.
Results: 182(56.1%)of the 324 acute STEMI patients with MV- CAD underwent the
second angiography in 90 day after p-PCI. We performed second PCI only 144 of 182
(79.1%) STEMI patients with MV-CAD.After the p-PCI, LS-PCI group had tending
to increase rate of stable angina pectoris (13.5% vs. 3.6%, p¼0.053) and had
signiﬁcantly higher acute coronary syndrome (24.7% vs 5,5%, p¼ 0.003) in compared
with ES-PCI group.Conclusions: Step-wise treatment is better treatment strategy instead of complete
revascularization during the index PCI for acute STEMI patients with critical MV-
CAD.We concluded performing the s-PCI to non-infarct related critical coronary ar-
tery lesions in the ﬁrst 15 days after index intervention.
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Background: Timely Primary percutaneous coronary intervention (PPCI) has
repeatedly been shown to be superior to ﬁbrinolytic treatment in randomized control
trials. The delay between ﬁrst medical contact (FMC) and reperfusion (’system delay’)
is most readily modiﬁable and predicts outcome. Ambulance service (EMS) has a
critical role in pre-hospital diagnosis, triage and timely transfer of these patients to
PCI-capable hospitals to minimize delay and optimize outcomes in STEMI patients. In
this study, we evaluated the impact of awareness campaign directed at EMS personnel
on door-to-balloon times over a 3- year period.
Methods: A series of one-day refresher courses, directed at EMS personnel to increase
awareness, were conducted at our center. Data on door-to-balloon times for the patients
admitted via Emergency department (ED) or direct to catheterization laboratory was
prospectively recorded. The door-to-balloon times for the two groups were compared and
the number of patients who breeched the target door-to-balloon times was also recorded.
Results: Out of the 728 patients included in the study, a total of 106 (14.6%) patients
breeched the target of < 90 minutes door-to-balloon time. Majority of these patients
(88%) (n¼93) were admitted via ED for PPCI. In contrast, only 8 out of 484 patients
who were directly admitted to the catheterization laboratory breeched the door-to-
balloon target. Following the refresher courses, the number of patients admitted via
ED for PPCI reduced signiﬁcantly with a simultaneous increase in the number of
patients brought directly to the catheterization laboratory. Overall, median door-to-
balloon time in the patients who bypassed ED was signiﬁcantly lower than those
admitted via ED (37 minutes (range 17-132) vs. 83 minutes (range 30-292), p< 0.05).
Similarly, median call-to-balloon time was signiﬁcantly lower in the patients admitted
directly to the catheterization laboratory as compared to patients admitted via ED (97
minutes vs.144 minutes, p< 0.05)
Conclusions: This study demonstrates that increasing awareness in EMS personnel
results in signiﬁcant reduction in door-to-balloon times by bypassing ED.ute Myocardial Infarction B17
